Published: Jun. 2, 2023 at 7:45 PM EDT|Updated: 9 hours ago
NEW YORK, June 2, 2023 /PRNewswire/ —
WHY: Rosen Law Firm, a global investor rights law firm, continues
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages YS Biopharma Co., Ltd. f/k/a Summit Healthcare Acquisition Corp. Investors to Inquire About Securities